DUBLIN – April 17, 2018 – Medtronic plc (NYSE: MDT) today announced its U.S. launch of OptiSphere(TM) embolization spheres, a resorbable embolic platform designed for embolization of hypervascular tumors. OptiSphere offers patients an alternative treatment option, a resorbable embolic, with comparable results to a permanent embolic.1 Hypervascular tumors can present as […]
Tag: Interventional Oncology
Surefire Medical Presents Registry Data for Treatment of Liver Cancer at the 2018 SIR Annual Meeting
LOS ANGELES–(BUSINESS WIRE)–Surefire Medical, Inc. (Surefire), an oncology drug delivery company, announced today the presentation of data analyzing the efficacy and safety from its national patient registry. The data were presented as part of the 2018 Society for Interventional Radiology (SIR) Annual Meeting in Los Angeles, CA from March 17-22, 2018. […]
Varian to Discuss Agreement to Acquire Sirtex
PALO ALTO, Calif., Jan. 30, 2018 /PRNewswire/ — Varian (NYSE: VAR) today announced that it will webcast a conference call to discuss the details of the agreement, also announced today, to acquire all the outstanding shares of Sirtex Medical. Sirtex is an Australia-based global life sciences company focused on interventional oncology therapies, that is […]